Let’s Paint the Town BLUE

It’s National Diabetes Awareness Month, it is time to paint the town BLUE! You have done a fantastic job fundraising for our Walk; now, let’s challenge the community!  Contact your local school and ask them to fundraise for JDRF! Fundraisers can be as easy as a jeans day, spare change collection, paper sneaker sale, or […]

National Diabetes Awareness Month

Each November we take time to celebrate National Diabetes Awareness Month.  Please take time to share your passion for JDRF and T1D.  Take the time to educate everyone you know about type 1 and how JDRF strives to treat, cure and prevent T1D.  Share our emails and Facebook posts; direct friends and co-workers to our […]

Our #1 for November – Evan Van Vorhis

Evan was diagnosed with Type 1 Diabetes at age 4. It was discovered after a steroids treatment for Asthma. Hours later Evan was extremely thirsty and running to the bathroom a lot. At naptime, I noticed her breath smelled like a banana. I instantly thought, “Is that Diabetes? I mean what are the chances she […]

Let’s Talk Turkey

A holiday centered around food could be a nightmare for anyone managing T1D. To help you navigate the coming food-filled holiday, we found a couple interesting articles.  First, there is a list of Dos and Don’ts that could make the holiday season a little smoother. Thanksgiving can also be a time when you can educate […]

Making the T1D Vaccine a Reality

Nanoparticle-based vaccine is designed to re-educate the immune system and halt the attack on the pancreas Over the last three years, Selecta Bioscience, a clinical stage biotechnology company, has been developing nanoparticles called Synthetic Vaccine Particle (SVP) as an immunotherapy for Type 1 diabetes (T1D) with support from JDRF and it was announced this week […]

JDRF-Funded Research Leads to Beta Cell Replacement Breakthrough

A new method for converting stem cells to beta cells could speed encapsulated cell replacement product development and research to cure type 1 diabetes Insulin therapy has long been the only method of treating type 1 diabetes (T1D), but a major breakthrough in producing replacement beta cells is bringing new hope that more effective, alternative […]

T1D Vaccine?

Selecta Biosciences and JDRf have extended their joint research collaboration and added Sanofi as a partner in support of their program to develop immunotherapy for the treatment and prevention of the underlying cause of type 1 diabetes.  This ground breaking therapy is designed to reset the immune system and restore tolerance to substances (antigens) that […]

JDRF 2015 Children’s Congress application site remains open

JDRF is pleased to announce that applications for JDRF 2015 Children’s Congress are currently being accepted. JDRF Children’s Congress, our highest profile advocacy event, is held every two years in the nation’s capital. Next year’s event will take place from July 13 to 15, 2015. It will include more than 150 children, ages 4 to […]

CGM-Medicare Bill Introduced in House

JDRF Commends U.S. Representatives Reed, DeGette and Whitfield for Introducing Continuous Glucose Monitor (CGM) Coverage Legislation JDRF commends U.S. Representatives Tom Reed (R-NY), Diana DeGette (D-CO) and Ed Whitfield (R-KY) for introducing legislation, H.R. 5644, the ‘Medicare CGM Access Act of 2014,’ calling for continuous glucose monitor (CGM) coverage by Medicare. This legislation (which now […]